OHSU
Welcome,         Profile    Billing    Logout  
 110 Trials 
233 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Treggiari, Miriam
PreVent 2, NCT03705286: Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia

Completed
2
1074
US
EVAC-PU-ETT, Shiley™ Evac Oral Tracheal Tube, SealGuard™, Murphy Eye, PVC-ETT, Shiley™ Cuffed Basic Endotracheal Tube
Yale University, National Heart, Lung, and Blood Institute (NHLBI), Oregon Health and Science University
Ventilator-acquired Pneumonia
02/23
02/23
NCT04483973: SPI-1005 Treatment in Severe COVID-19 Patients

Enrolling by invitation
2
60
US
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated
Covid19, Coronavirus, Coronavirus Infection, Corona Virus Infection
12/23
12/23
NCT04484025: SPI-1005 Treatment in Moderate COVID-19 Patients

Enrolling by invitation
2
60
US
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated
Covid19, Corona Virus Infection, Coronavirus, Coronavirus Infection
12/23
12/23
NCT02878850: Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury

Active, not recruiting
N/A
152
US
Augmented Blood Pressure
Oregon Health and Science University, United States Department of Defense
Spinal Cord Injury
08/23
08/24
NCT05957406: SMART TRENDS Study

Recruiting
N/A
244
US
Acumen HPI Smart Alerts and Smart Trends Software, The HemoSphere advanced monitoring platform with Acumen HPI software, and Acumen IQ sensor and Acumen IQ cuff
Edwards Lifesciences
Moderate to High-risk Noncardiac Surgery
10/25
06/26
Edelman, Alison B
EC-Obesity, NCT02863445: Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG

Completed
4
70
US
Levonorgestrel-based emergency contraception 1.5 mg, Plan B, Next Choice, Levonorgestrel-based emergency contraception 3.0mg
Oregon Health and Science University, National Institutes of Health (NIH)
Obesity
01/21
08/21
UPA-Obesity, NCT02859337: Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA

Completed
4
64
US
UPA-ECx1, Ella, Ella-One, UPA-ECx2, ella, ella-one
Oregon Health and Science University, National Institutes of Health (NIH)
Obesity, Contraception
01/22
11/23
NCT06000423: Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects

Recruiting
4
48
US
Tranexamic acid, TXA, Placebo
Oregon Health and Science University, Bill and Melinda Gates Foundation
Bleeding, Contraceptive Device; Complications
08/25
01/26
NCT05674513: Disparities in Emergency Contraceptive Metabolism Dictate Efficacy

Recruiting
4
140
US
Ulipristal acetate
Oregon Health and Science University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Contraceptive Usage
12/26
12/27
NCT05041699: PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel

Completed
1/2
40
US
IPM Ring-105, IPM Ring-106
International Partnership for Microbicides, Inc., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)
Pharmacokinetics, Safety Issues, Bleeding
10/24
10/24
NCT05760144: Endometrial Biopsy in Progestin Contraceptive Users

Recruiting
1
52
US
DMPA, Depo-Provera, Etonogestrel implant, Nexplanon
Oregon Health and Science University
Contraception
11/26
11/26
NCT06127199: Contraceptive Efficacy Study of Ovaprene

Recruiting
N/A
656
US
Ovaprene
Daré Bioscience, Inc., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Contraception
06/25
09/25
NCT05848908: Advanced Provision of Care

Active, not recruiting
N/A
200
US
Telehealth Visit
Oregon Health and Science University
Pregnancy Related
06/25
06/25
Vuky, Jacqueline
SHIELD-RT, NCT03775265: Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Active, not recruiting
3
475
US
Atezolizumab, MPDL 3280A, MPDL 328OA, MPDL-3280A, MPDL3280A, MPDL328OA, RG 7446, RG-7446, RG7446, RO 5541267, RO-5541267, RO5541267, Tecentriq, Biopsy of Bladder, Bladder Biopsy, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Cystoscopy, CS, Fluorouracil, 5 Fluorouracil, 5 Fluorouracilum, 5 FU, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-Fu, 5FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Gemcitabine, dFdC, dFdCyd, Difluorodeoxycytidine, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Mitomycin, Ametycine, Jelmyto, MITO, Mito-C, Mito-Medac, Mitocin, Mitocin-C, Mitolem, Mitomycin C, Mitomycin pyelocalyceal, Mitomycin-C, Mitomycin-X, Mitomycine C, Mitosol, Mitozytrex, Mutamycin, Mutamycine, NCI-C04706, Quality-of-Life Assessment, Quality of Life Assessment, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Survey Administration, Transurethral Resection of Bladder Tumor, Transurethral resection (TURBT), TURBT
National Cancer Institute (NCI)
Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8
06/27
06/27
KEYNOTE-D38, NCT05077709: IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

Active, not recruiting
2
63
Europe, US
IO102-IO103 in combination with pembrolizumab
IO Biotech, Theradex, Almac, NeoGenomics, Merck Sharp & Dohme LLC
Lung Cancer Non Small Cell, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma Bladder
01/24
11/24
NCT02312557: Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Active, not recruiting
2
58
US
Enzalutamide, ASP9785, MDV3100, Xtandi, Laboratory Biomarker Analysis, Pembrolizumab, Keytruda, Lambrolizumab, MK-3475, SCH 900475
OHSU Knight Cancer Institute, Merck Sharp & Dohme LLC, Collins Medical Trust, Oregon Health and Science University
Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression, Recurrent Prostate Carcinoma, Stage IV Prostate Adenocarcinoma Cancer AJCC v8
08/24
06/25
DCC-3014-01-001, NCT03069469: Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Active, not recruiting
1/2
120
Europe, Canada, US, RoW
Vimseltinib, DCC-3014
Deciphera Pharmaceuticals, LLC
Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Tenosynovial Giant Cell Tumor, Diffuse
07/26
08/28
Martin, William H
NCT05016674: Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat

Withdrawn
N/A
3
US
LipoLife system
Alma Lasers
Laser Assisted Liposuction
02/23
05/23
Huang, David
ACTIV-4, NCT04505774 / 2020-004285-19: Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE

Completed
4
3591
Europe, US, RoW
theraputic heparin, unfractionated heparin, Enoxaparin, Dalteparin, Tinzaparin, Heparin, prophylactic heparin, enoxaparin, dalteparin, Fondparinux, P2Y12, Ticagrelor, Prasugrel, Clopidogrel, Crizanlizumab Injection, SGLT2 inhibitor, dapagliflozin, empagliflozin, canagliflozin, ertugliflozin
Matthew Neal MD, National Heart, Lung, and Blood Institute (NHLBI)
Covid19
08/23
01/24
PIVATAL, NCT05034432: The Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

Recruiting
4
100
US
Intra-Op Prophylactic VT ablation, Conventional Management
University of Rochester, National Heart, Lung, and Blood Institute (NHLBI)
Arrythmia, Cardiomyopathies
12/25
06/26
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Terminated
3
535
Europe, Canada, Japan, US, RoW
BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo
Remedy Pharmaceuticals, Inc.
Brain Edema, Stroke, Acute
08/23
08/23
ASPIRE, NCT03907046: Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Recruiting
3
700
US
Apixaban, Eliquis, Aspirin
Yale University, National Institute of Neurological Disorders and Stroke (NINDS)
Intracerebral Hemorrhage, Atrial Fibrillation
04/27
04/27
REPAVID-22, NCT05254990 / 2021-006951-32: Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Terminated
3
409
Europe, US, RoW
Reparixin, Repertaxin L-lysine salt, Placebo, Matched placebo
Dompé Farmaceutici S.p.A
Infectious Pneumonia, Severe COVID-19
09/24
09/24
NRG-BN013, NCT06500455: Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Recruiting
3
269
US
Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Fractionated Stereotactic Radiation Therapy, Fractionated Stereotactic Radiotherapy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Stereotactic Radiosurgery, SRS, Stereotactic External Beam Irradiation, stereotactic external-beam radiation therapy, Stereotactic Radiation Therapy, Stereotactic Radiotherapy, stereotaxic radiation therapy, stereotaxic radiosurgery
NRG Oncology, National Cancer Institute (NCI)
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Metastatic Renal Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8
06/28
06/28
NCT04258787: OCT in Fuchs' Dystrophy

Recruiting
N/A
60
US
Oregon Health and Science University, National Eye Institute (NEI)
Fuchs Dystrophy, Pseudophakic Bullous Keratopathy
06/26
06/26
NCT01243931: Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Recruiting
N/A
80
US
OCT-guided laser phototherapeutic keratectomy, Manufacturer/Name OCT Technology 510(K), Optovue/RTVue-CAM Fourier-domain K071250, Bioptigen/Bioptigen Fourier-domain K063343, Zeiss/Visante Time-domain K051789
Oregon Health and Science University, National Eye Institute (NEI)
Corneal Opacity
12/26
12/26
NCT02109471: Observational Study of Corneal Opacities in Adults

Recruiting
N/A
150
US
Oregon Health and Science University, National Eye Institute (NEI)
Corneal Opacities (Scar and Stromal Dystrophy)
12/25
12/25
NCT02026128: Optical Coherence Tomography (OCT) in Uveitis

Recruiting
N/A
75
US
Oregon Health and Science University
Uveitis
12/25
12/25
NCT02141308: OCT in Rare Chorioretinal Diseases

Recruiting
N/A
150
US
Oregon Health and Science University
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
12/25
12/26
NCT03761381: OCT Angiography and NRAI in Dementia

Recruiting
N/A
20
US
Optical Coherence Tomography Angiography (OCTA) Imaging, Noninvasive Retinal Amyloid Imaging (NRAI)
Oregon Health and Science University
Alzheimer Disease, Dementia, Mild Cognitive Impairment
12/25
12/25
NCT03504800: OCT in Diagnosis of Irregular Corneas

Recruiting
N/A
445
US
Optical Coherence Tomography
Oregon Health and Science University
Keratoconus, Corneal Opacity, Corneal Dystrophy
04/25
04/26
OCT IOL, NCT00532051: Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography

Recruiting
N/A
690
US
OCT measurements, Manufacturer/Name OCT Technology 510(K), Optovue/RTVue-CAM Fourier-domain K071250, Bioptigen/Bioptigen Fourier-domain K063343, Zeiss/Visante Time-domain K051789
Oregon Health and Science University, National Eye Institute (NEI)
Cataract
07/26
07/26
NCT04190186: Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation

Completed
N/A
55
US
Insertable Cardiac Monitor, BioMonitor3® or future generation of Biotronik ICM
University of Rochester, Biotronik, Inc.
Persistent Atrial Fibrillation
02/24
02/24
NCT03760432: Collagen Cross-linking in Keratoconus

Recruiting
N/A
100
US
Laser Custom Corneal Collagen Cross-Linking
Oregon Health and Science University, National Eye Institute (NEI)
Keratoconus
12/25
12/25
NCT03809585: Observational Study of Iris Tumors

Recruiting
N/A
100
US
Oregon Health and Science University, National Eye Institute (NEI)
Iris Tumor
12/25
12/25
ICMREDUCE-AF, NCT04922281: Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation

Recruiting
N/A
120
US
Insertable Cardiac Monitor or external non-invasive LT-ECG patch, Confirm Rx™, Carnation Ambulatory Monitor ("CAM™"; Bardy Diagnostics).The CAM™ patch.
University of Rochester, National Heart, Lung, and Blood Institute (NHLBI)
Atrial Fibrillation, Cardiovascular Diseases, Heart Diseases, Arrhythmias, Cardiac, Pathologic Processes
09/25
12/25
NCT04570020: Scleral Lens Fitting Using Wide-Field OCT

Recruiting
N/A
258
US
Oregon Health and Science University, National Eye Institute (NEI)
Keratoconus, Irregular; Contour of Cornea
12/25
12/26
FSOCT, NCT01957267: Functional and Structural Imaging for Glaucoma

Recruiting
N/A
160
US
Oregon Health and Science University, National Eye Institute (NEI)
Glaucoma
05/26
05/26
NCT01931904: Eye Pressure Lowering Surgery

Recruiting
N/A
46
US
Oregon Health and Science University, National Eye Institute (NEI)
Glaucoma
05/26
05/26
VA IR vs IO, NCT05250986: Comparison of Visual Acuity Performed in Office Versus In Residence

Recruiting
N/A
325
US, RoW
GoCheck Kids (iOS), GoCheck Kids (Windows), GoCheck at Home (iOS), GoCheck at Home (Windows)
Gobiquity Mobile Health
Refractive Errors
05/22
09/22
Hwang, Thomas
NCT02141308: OCT in Rare Chorioretinal Diseases

Recruiting
N/A
150
US
Oregon Health and Science University
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
12/25
12/26
NCT02253030: OCT Angiography in Wet AMD

Recruiting
N/A
160
US
Optical Coherence Tomography
Oregon Health and Science University
Neovascular (Wet) Age-related Macular Degeneration (AMD)
12/26
12/26
NCT02330042: OCT Biomarkers for Diabetic Retinopathy

Active, not recruiting
N/A
165
US
Oregon Health and Science University
Diabetic Retinopathy
12/24
12/24
NCT03922932: WF and PR OCTA in Diabetic Retinopathy

Active, not recruiting
N/A
290
US
Oregon Health and Science University
Diabetic Retinopathy
12/25
12/25
Spurgeon, Stephen
EA4181, NCT04115631: A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

Active, not recruiting
2
360
US
Acalabrutinib, ACP-196, Bruton Tyrosine Kinase Inhibitor ACP-196, Calquence, Bendamustine, SDX-105, Bendamustine Hydrochloride, Bendamustin Hydrochloride, Bendeka, Cytostasan Hydrochloride, Levact, Ribomustin, SyB L-0501, Treanda, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Rituximab, ABP 798, BI 695500, C2B8 Monoclonal Antibody, Chimeric Anti-CD20 Antibody, CT-P10, IDEC-102, IDEC-C2B8, IDEC-C2B8 Monoclonal Antibody, MabThera, Monoclonal Antibody IDEC-C2B8, PF-05280586, Rituxan, Rituximab ABBS, Rituximab Biosimilar ABP 798, Rituximab Biosimilar BI 695500, Rituximab Biosimilar CT-P10, Rituximab Biosimilar GB241, Rituximab Biosimilar IBI301, Rituximab Biosimilar JHL1101, Rituximab Biosimilar PF-05280586, Rituximab Biosimilar RTXM83, Rituximab Biosimilar SAIT101, rituximab biosimilar TQB2303, rituximab-abbs, RTXM83, Truxima
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Liver Lymphoma, Mantle Cell Lymphoma
12/25
12/25
NCT06895473: Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

Not yet recruiting
2
22
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-Cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Lumbar Puncture, LP, Spinal Tap, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Jylamvo, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Therapeutic Hydrocortisone, Aeroseb-HC, Barseb HC, Barseb-HC, Cetacort, Cort-Dome, Cortef, Cortenema, Cortifan, Cortisol, Cortispray, Cortril, Dermacort, Domolene, Eldecort, Hautosone, Heb-Cort, Hydrocortisone, Hydrocortone, Hytone, Komed-HC, Nutracort, Proctocort, Rectoid
OHSU Knight Cancer Institute, Oregon Health and Science University, American Society of Clinical Oncology
Hematopoietic and Lymphatic System Neoplasm
04/27
12/27
PRO1160-001, NCT05721222: PRO1160 for Advanced Solid and Liquid Tumors

Recruiting
1/2
134
US, RoW
PRO1160
ProfoundBio US Co.
Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma
11/26
03/27
NCT06357676: Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma

Not yet recruiting
1/2
27
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Echocardiography, EC, FDG-Positron Emission Tomography, FDG, FDG-PET, FDG-PET Imaging, Glofitamab, Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody RO7082859, RO 7082859, RO7082859, Ibrutinib, BTK Inhibitor PCI-32765, CRA-032765, Imbruvica, PCI-32765, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Obinutuzumab, Anti-CD20 Monoclonal Antibody R7159, GA-101, GA101, Gazyva, huMAB(CD20), R7159, RO 5072759, RO-5072759, RO5072759
OHSU Knight Cancer Institute, Oregon Health and Science University, Genentech, Inc.
Mantle Cell Lymphoma
05/27
05/29
NCT06249191: Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

Recruiting
1/2
30
US
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspiration and Biopsy, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B-518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, WR-138719, Doxorubicin, Adriablastin, Hydroxydaunomycin, Hydroxyl Daunorubicin, Hydroxyldaunorubicin, Echocardiography, EC, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP 16213, VP-16, VP-16-213, VP16, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Mosunetuzumab, Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody BTCT4465A, BTCT 4465A, BTCT-4465A, BTCT4465A, CD20/CD3 BiMAb BTCT4465A, Lunsumio, Mosunetuzumab-axgb, RG 7828, RG-7828, RG7828, RO7030816, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Vincristine, LCR, Leurocristine, VCR, Vincrystine
OHSU Knight Cancer Institute, Genentech, Inc., Oregon Health and Science University
Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma
04/26
04/27
NCT05943496: Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Recruiting
1
25
US
Acalabrutinib, ACP-196, Bruton Tyrosine Kinase Inhibitor ACP-196, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Echocardiography, EC, Obinutuzumab, Anti-CD20 Monoclonal Antibody R7159, GA-101, GA101, Gazyva, huMAB(CD20), R7159, RO 5072759, RO-5072759, RO5072759, Questionnaire Administration, Tafasitamab, Immunoglobulin, Anti-(Human Cd19 Antigen) (Human-mus musculus Monoclonal MOR00208 Heavy Chain), Disulfide with Human-mus musculus Monoclonal MOR00208 .Kappa.-chain, Dimer, Monjuvi, MOR-00208, MOR00208, MOR208, Tafasitamab-cxix, XmAb5574
OHSU Knight Cancer Institute, Oregon Health and Science University, Incyte Corporation
Chronic Lymphocytic Leukemia
01/26
01/27
Davidson, Brian R
EMT2, NCT03428477 / 2016-000628-24: EPA for Metastasis Trial 2

Active, not recruiting
3
418
Europe
Icosapent Ethyl, Vascepa, Placebo
Mark A Hull, PhD FRCP, Yorkshire Cancer Research, Amarin Pharma Inc.
Liver Metastasis, Colon Cancer
11/25
04/26
NCT03195556: Augmentation of Limb Perfusion With Contrast Ultrasound

Recruiting
N/A
30
US
Ultrasound, Contrast ultrasound
Oregon Health and Science University
Peripheral Arterial Disease
12/19
12/19
Vaseghi, Marmar
PREVENT VT, NCT01013714: Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias

Recruiting
3
40
US
Cardiac Sympathetic Denervation (CSD), Routine Care
University of California, Los Angeles, Oregon Health and Science University
Sudden Cardiac Death, Ventricular Tachycardia, Ventricular Fibrillation, Cardiomyopathy
08/24
08/24
NCT04387435: Optimization of VNS in Epileptic Patients to Induce Cardioprotection

Completed
N/A
1
US
A change or titration in the current or frequency settings of the VNS therapy system.
University of California, Los Angeles, National Institutes of Health (NIH)
Epilepsy, Sudden Cardiac Death
07/21
07/21
NCT04359004: A Study to Evaluate the Effect of Vagus Nerve Stimulation in Patients Undergoing VT Ablation

Completed
N/A
5
US
Vagus Nerve Stimulation (VNS)
University of California, Los Angeles, National Institutes of Health (NIH)
Arrhythmia, Ventricular Tachycardia (VT)
06/23
10/23
tVNS_POAF, NCT04514757: Transcutaneous (Tragus) Vagal Nerve Stimulation for Post-op Afib

Completed
N/A
77
US
active tVNS, sham tVNS
University of California, Los Angeles, University of Oklahoma
Atrial Fibrillation
03/24
04/24
Klein, Michael
AMLSG BiO, NCT01252485: Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - the Biology and Outcome (BiO)-Project

Recruiting
N/A
50000
Europe
University of Ulm
Acute Myeloid Leukemia (AML), MDS/AML
12/44
12/44
NCT02141308: OCT in Rare Chorioretinal Diseases

Recruiting
N/A
150
US
Oregon Health and Science University
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
12/25
12/26
NCT02253030: OCT Angiography in Wet AMD

Recruiting
N/A
160
US
Optical Coherence Tomography
Oregon Health and Science University
Neovascular (Wet) Age-related Macular Degeneration (AMD)
12/26
12/26
King, Laurie
reTURN, NCT03892291: Objective Dual-task Turning Measures for Return-to-duty Assessments

Active, not recruiting
N/A
140
US
Oregon Health and Science University, Courage Kenny Research Center, University of Utah, Fort Sam Houston, Warrior Recovery Center, Madigan Army Medical Center
Mild Traumatic Brain Injury, Gait, Balance, Veterans, Mobility
08/24
08/24
NCT03479541: Can Early Initiation of Rehabilitation With Wearable Sensor Technology Improve Outcomes in mTBI?

Active, not recruiting
N/A
160
US
Rehabilitation
Oregon Health and Science University, United States Department of Defense
Mild Traumatic Brain Injury, Balance; Distorted, Gait, Unsteady, Quality of Life, Veterans
09/23
09/23
SuBTyPE, NCT06381674: Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation

Recruiting
N/A
100
US
Vestibular therapy for mTBI augmented with audio and visual real-time biofeedback, Rehabilitation, Vestibular therapy for mTBI
Oregon Health and Science University, United States Department of Defense
Mild Traumatic Brain Injury, Concussion, Rehabilitation, Balance Impairment
09/28
09/28
NCT05680597: Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease

Recruiting
N/A
80
US
Balance Tele-Rehabilitation Agility Boot Camp (ABC), Opal sensors; APDM Wearable Technologies
Oregon Health and Science University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Parkinson Disease
06/27
06/27
Cichowski, Sara
RELIEF, NCT05512039: Reduced-dose Botox for Urgency Incontinence Among Elder Females

Recruiting
1/2
376
US
Botox 50 Unit Injection, OnabotulinumtoxinA 50 Unit Injection, Botox 100 Unit Injection, OnabotulinumtoxinA 100 Unit
Dartmouth-Hitchcock Medical Center, Patient-Centered Outcomes Research Institute, Dartmouth College, University of Alabama at Birmingham, University of Pittsburgh, University of Texas, Kaiser Permanente, Oregon Health and Science University, Stanford University, University of Connecticut, University of Nebraska
Overactive Bladder, Urinary Incontinence in Old Age, Urgency Urinary Incontinence
09/26
01/27
NCT05950633: Postoperative Active Recovery

Active, not recruiting
N/A
72
US
Standard of Care, Active Recovery
Oregon Health and Science University
Pelvic Floor Disorders
04/25
04/25
Lauer, Andreas
NCT02141308: OCT in Rare Chorioretinal Diseases

Recruiting
N/A
150
US
Oregon Health and Science University
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
12/25
12/26
NCT02253030: OCT Angiography in Wet AMD

Recruiting
N/A
160
US
Optical Coherence Tomography
Oregon Health and Science University
Neovascular (Wet) Age-related Macular Degeneration (AMD)
12/26
12/26
NCT03922932: WF and PR OCTA in Diabetic Retinopathy

Active, not recruiting
N/A
290
US
Oregon Health and Science University
Diabetic Retinopathy
12/25
12/25
Bailey, Steven
NCT02141308: OCT in Rare Chorioretinal Diseases

Recruiting
N/A
150
US
Oregon Health and Science University
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
12/25
12/26
NCT02253030: OCT Angiography in Wet AMD

Recruiting
N/A
160
US
Optical Coherence Tomography
Oregon Health and Science University
Neovascular (Wet) Age-related Macular Degeneration (AMD)
12/26
12/26
CHIPAHA, NCT00763828: Can Hypothermia be Incorporated Into Primary Angioplasty for Heart Attack?

Not yet recruiting
N/A
20
US
Life Recovery Systems ThermoSuit, Life Recovery Systems ThermoSuit(R) System
Life Recovery Systems
ST-Elevation Myocardial Infarction
02/25
05/25
Taylor, Matthew
OpcemISA, NCT03669718 / 2018-000789-13: A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Active, not recruiting
2
194
Europe, US, RoW
ISA101b, Cemiplimab, Placebo
ISA Pharmaceuticals, Regeneron Pharmaceuticals
Squamous Cell Carcinoma of the Oropharynx, HPV16 Positive
09/24
06/25
NCT05308901: Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma

Active, not recruiting
2
6
US
Pembrolizumab, Keytruda, Lenvatinib
Providence Health & Services, Merck Sharp & Dohme LLC, Eisai Inc.
Melanoma, Uveal
12/24
06/27
CA209-73R, NCT04061980: Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer

Active, not recruiting
2
24
US
Binimetinib, ARRY-162, ARRY-438162, MEK162, Mektovi, Encorafenib, Braftovi, LGX 818, LGX-818, LGX818, Nivolumab, BMS-936558, MDX-1106, NIVO, ONO-4538, Opdivo
Providence Health & Services, Providence Cancer Center, Earle A. Chiles Research Institute
BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma, Refractory Thyroid Gland Carcinoma, Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8, Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8, Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
10/25
10/27
NCT04938609: Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

Active, not recruiting
2
28
US
Pembrolizumab, Keytruda, Stereotactic Body Radiation Therapy (5 days), Surgical Resection
Providence Health & Services, Providence Cancer Center, Earle A. Chiles Research Institute
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
01/27
01/31
NCT05200143: Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma

Terminated
2
4
US
Ipilimumab, Nivolumab, BMS-936558, MDX1106, ONO-4538, Cabozantinib, XL184
Providence Health & Services, Bristol-Myers Squibb, Exelixis
Refractory Cutaneous Melanoma
09/23
07/24
NCT05913388: GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma

Recruiting
2
92
US
GB1211, Pembrolizumab, Keytruda, Placebo
Providence Health & Services, Providence Cancer Center, Providence Cancer Center, Earle A. Chiles Research Institute, Galecto Biotech AB
Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma
02/28
02/30
BA3071-001, NCT05180799: A Phase 1/2 Study of BA3071 in Patients With Solid Tumors

Recruiting
1/2
320
US, RoW
BA3071, Nivolumab, Pembrolizumab, Pemetrexed (Alimta)
BioAtla, Inc.
NSCLC, Melanoma
12/25
06/26
KEYNOTE-E64, NCT04787042: Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Recruiting
1/2
316
US
ST-067, Obinutuzumab 25 MG/1 ML Intravenous Solution [GAZYVA], GAZYVA, pembrolizumab, KEYTRUDA®
Simcha IL-18, Inc., Merck Sharp & Dohme LLC
Cancer, Solid Tumor, Melanoma, Renal Cell Carcinoma, Triple-negative Breast Cancer, Non Small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Carcinoma, MSI-High
06/25
12/25
EP0031-101, NCT05443126: A Study of EP0031 in Patients With Advanced RET-altered Malignancies

Recruiting
1/2
265
Europe, US, RoW
EP0031
Ellipses Pharma
Advanced Solid Tumor
12/26
06/27
IO-108-CL-001, NCT05054348: First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors

Completed
1
91
US
IO-108, IO-108 + pembrolizumab combination therapy, IO-108 + Keytruda combination therapy, IO-108 + cemiplimab combination therapy, IO-108 + Libtayo combination therapy
Immune-Onc Therapeutics, Regeneron Pharmaceuticals
Solid Tumor, Adult
04/24
05/24
NCT01107522: Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Active, not recruiting
1
100
US
CTO, CTO and Temodar®, CTO, Temodar®, Radiation therapy
Tactical Therapeutics, Inc.
Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas
01/25
01/26
RIDGE-1, NCT06228924: Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults with PKP2 Mutation-associated ARVC

Recruiting
1
15
US
TN-401
Tenaya Therapeutics, Johns Hopkins University, Mayo Clinic
Arrhythmogenic Right Ventricular Cardiomyopathy
05/26
10/29
STARLING, NCT05576077: A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

Terminated
1
31
Canada, US
TBio-4101, TIL, autologous, tumor-reactive, T-cell product, Pembrolizumab, Keytruda
Turnstone Biologics, Corp.
Breast Cancer, Colorectal Cancer, Uveal Melanoma, Cutaneous Melanoma, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma
02/25
02/25
NCT03882437: Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B

Active, not recruiting
1
7
US
RP-A501
Rocket Pharmaceuticals Inc.
Danon Disease
03/25
03/25
C-1100-01, NCT04121676: Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

Completed
1
91
US
AGEN2373, Anti-CD137, Botensilimab, AGEN1181, Anti-CTLA-4
Agenus Inc.
Advanced Cancer
02/24
11/24
RIDGE, NCT06311708: Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Recruiting
N/A
200
Europe, US
Tenaya Therapeutics, University of California, San Francisco, Brigham and Women's Hospital, New York University, University of Colorado, Denver, Johns Hopkins University, The Cleveland Clinic, Mayo Clinic, Medical University of South Carolina, Hopital Louis Pradel, Istituti Clinici Scientifici Maugeri SpA, The Queen Elizabeth Hospital, St George's University Hospitals NHS Foundation Trust, Royal Brompton & Harefield NHS Foundation Trust, Barts & The London NHS Trust, Skane University Hospital, Centro Cardiologico Monzino, Hôpital Haut-Lévêque, Nantes University Hospital, Pitié-Salpêtrière Hospital, Wuerzburg University Hospital, University Hospital Muenster
Arrhythmogenic Right Ventricular Cardiomyopathy
03/30
07/30
NCT05389514: Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Temporarily Not Available
N/A
NA
Cyclophosphamide, Cytoxan, Cytoxan Lyophilized, Cy, Gemcitabine, Gemzar, Pembrolizumab, KEYTRUDA, MK-3475, Cell Infusion
Providence Health & Services
KRAS G12V Mutant Advanced Epithelial Cancers
 
 
NCT06214507: Danon Disease Natural History Study

Recruiting
N/A
46
Europe, US, RoW
No intervention
Rocket Pharmaceuticals Inc.
Danon Disease
08/26
08/26
kidNEY-VNS, NCT05588063: taVNS for FRNS in Children

Recruiting
N/A
30
US
Transcutaneous auricular vagus nerve stimulation, Roscoe TENS 7000, Sham device
Northwell Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis
08/25
08/25
CABA, NCT05383833: Creatine to Augment Bioenergetics in Alzheimer's

Completed
N/A
20
US
Creatine Monohydrate
University of Kansas Medical Center, Alzheimer's Association
Alzheimer's Disease
05/24
05/24
kidNEY-VNS, NCT05583942: A Pilot Trial of taVNS for SRNS in Children

Recruiting
N/A
10
US
trascutaneous auricular vagus nerve stimulation, Roscoe TENS 7000, Sham device
Northwell Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis
04/25
08/25
Edmunds, Beth
FSOCT, NCT01957267: Functional and Structural Imaging for Glaucoma

Recruiting
N/A
160
US
Oregon Health and Science University, National Eye Institute (NEI)
Glaucoma
05/26
05/26
NCT01931904: Eye Pressure Lowering Surgery

Recruiting
N/A
46
US
Oregon Health and Science University, National Eye Institute (NEI)
Glaucoma
05/26
05/26
Skalet, Alilson
NCT01955915: Blood Vessel Patterns in Small Choroidal Tumors

Active, not recruiting
N/A
15
US
OHSU Knight Cancer Institute
Small Posterior Choroidal Tumors
04/15
12/23
Skalet, Alison
AL, NCT05844982: Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 Mg) Intravitreal Implants Vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Recruiting
3
600
US
Faricimab, fluocinolone acetonide
Jaeb Center for Health Research, National Eye Institute (NEI), National Institutes of Health (NIH), Alimera Sciences, Genentech, Inc.
Radiation Retinopathy, Visual Impairment
12/29
12/29
NCT01955941: Vascular Response to Brachytherapy Using Functional OCT

Completed
N/A
49
US
OHSU Knight Cancer Institute
Uveal Melanoma
11/21
11/21
NCT05266430: Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)

Terminated
N/A
2
US
Standard of Care, AU-011, belzupacap sarotalocan, bel-sar
Aura Biosciences
Choroidal Melanoma, Indeterminate Lesions
02/23
04/23
Hung, Arthur
NCT02565498: Preoperative vs Postoperative IMRT for Extremity/Truncal STS

Active, not recruiting
3
210
Europe, Canada, US
Preoperative intensity modulated radiation therapy, Postoperative intensity modulated radiation therapy
Mount Sinai Hospital, Canada, Princess Margaret Hospital, Canada
Adult Soft Tissue Sarcoma
10/24
05/29
DEBRA, NCT04852887: De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer

Recruiting
3
1670
Canada, Japan, US, RoW
Radiation and Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane), Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane)
NRG Oncology, National Cancer Institute (NCI)
Stage I Breast Cancer
01/26
07/41
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Treggiari, Miriam
PreVent 2, NCT03705286: Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia

Completed
2
1074
US
EVAC-PU-ETT, Shiley™ Evac Oral Tracheal Tube, SealGuard™, Murphy Eye, PVC-ETT, Shiley™ Cuffed Basic Endotracheal Tube
Yale University, National Heart, Lung, and Blood Institute (NHLBI), Oregon Health and Science University
Ventilator-acquired Pneumonia
02/23
02/23
NCT04483973: SPI-1005 Treatment in Severe COVID-19 Patients

Enrolling by invitation
2
60
US
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated
Covid19, Coronavirus, Coronavirus Infection, Corona Virus Infection
12/23
12/23
NCT04484025: SPI-1005 Treatment in Moderate COVID-19 Patients

Enrolling by invitation
2
60
US
Ebselen, SPI-1005, Placebo
Sound Pharmaceuticals, Incorporated
Covid19, Corona Virus Infection, Coronavirus, Coronavirus Infection
12/23
12/23
NCT02878850: Randomized Trial of Early Hemodynamic Management of Patients Following Acute Spinal Cord Injury

Active, not recruiting
N/A
152
US
Augmented Blood Pressure
Oregon Health and Science University, United States Department of Defense
Spinal Cord Injury
08/23
08/24
NCT05957406: SMART TRENDS Study

Recruiting
N/A
244
US
Acumen HPI Smart Alerts and Smart Trends Software, The HemoSphere advanced monitoring platform with Acumen HPI software, and Acumen IQ sensor and Acumen IQ cuff
Edwards Lifesciences
Moderate to High-risk Noncardiac Surgery
10/25
06/26
Edelman, Alison B
EC-Obesity, NCT02863445: Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG

Completed
4
70
US
Levonorgestrel-based emergency contraception 1.5 mg, Plan B, Next Choice, Levonorgestrel-based emergency contraception 3.0mg
Oregon Health and Science University, National Institutes of Health (NIH)
Obesity
01/21
08/21
UPA-Obesity, NCT02859337: Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA

Completed
4
64
US
UPA-ECx1, Ella, Ella-One, UPA-ECx2, ella, ella-one
Oregon Health and Science University, National Institutes of Health (NIH)
Obesity, Contraception
01/22
11/23
NCT06000423: Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects

Recruiting
4
48
US
Tranexamic acid, TXA, Placebo
Oregon Health and Science University, Bill and Melinda Gates Foundation
Bleeding, Contraceptive Device; Complications
08/25
01/26
NCT05674513: Disparities in Emergency Contraceptive Metabolism Dictate Efficacy

Recruiting
4
140
US
Ulipristal acetate
Oregon Health and Science University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Contraceptive Usage
12/26
12/27
NCT05041699: PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel

Completed
1/2
40
US
IPM Ring-105, IPM Ring-106
International Partnership for Microbicides, Inc., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)
Pharmacokinetics, Safety Issues, Bleeding
10/24
10/24
NCT05760144: Endometrial Biopsy in Progestin Contraceptive Users

Recruiting
1
52
US
DMPA, Depo-Provera, Etonogestrel implant, Nexplanon
Oregon Health and Science University
Contraception
11/26
11/26
NCT06127199: Contraceptive Efficacy Study of Ovaprene

Recruiting
N/A
656
US
Ovaprene
Daré Bioscience, Inc., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Contraception
06/25
09/25
NCT05848908: Advanced Provision of Care

Active, not recruiting
N/A
200
US
Telehealth Visit
Oregon Health and Science University
Pregnancy Related
06/25
06/25
Vuky, Jacqueline
SHIELD-RT, NCT03775265: Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Active, not recruiting
3
475
US
Atezolizumab, MPDL 3280A, MPDL 328OA, MPDL-3280A, MPDL3280A, MPDL328OA, RG 7446, RG-7446, RG7446, RO 5541267, RO-5541267, RO5541267, Tecentriq, Biopsy of Bladder, Bladder Biopsy, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Cystoscopy, CS, Fluorouracil, 5 Fluorouracil, 5 Fluorouracilum, 5 FU, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-Fu, 5FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Gemcitabine, dFdC, dFdCyd, Difluorodeoxycytidine, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Mitomycin, Ametycine, Jelmyto, MITO, Mito-C, Mito-Medac, Mitocin, Mitocin-C, Mitolem, Mitomycin C, Mitomycin pyelocalyceal, Mitomycin-C, Mitomycin-X, Mitomycine C, Mitosol, Mitozytrex, Mutamycin, Mutamycine, NCI-C04706, Quality-of-Life Assessment, Quality of Life Assessment, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Survey Administration, Transurethral Resection of Bladder Tumor, Transurethral resection (TURBT), TURBT
National Cancer Institute (NCI)
Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8
06/27
06/27
KEYNOTE-D38, NCT05077709: IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

Active, not recruiting
2
63
Europe, US
IO102-IO103 in combination with pembrolizumab
IO Biotech, Theradex, Almac, NeoGenomics, Merck Sharp & Dohme LLC
Lung Cancer Non Small Cell, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma Bladder
01/24
11/24
NCT02312557: Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Active, not recruiting
2
58
US
Enzalutamide, ASP9785, MDV3100, Xtandi, Laboratory Biomarker Analysis, Pembrolizumab, Keytruda, Lambrolizumab, MK-3475, SCH 900475
OHSU Knight Cancer Institute, Merck Sharp & Dohme LLC, Collins Medical Trust, Oregon Health and Science University
Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression, Recurrent Prostate Carcinoma, Stage IV Prostate Adenocarcinoma Cancer AJCC v8
08/24
06/25
DCC-3014-01-001, NCT03069469: Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Active, not recruiting
1/2
120
Europe, Canada, US, RoW
Vimseltinib, DCC-3014
Deciphera Pharmaceuticals, LLC
Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Tenosynovial Giant Cell Tumor, Diffuse
07/26
08/28
Martin, William H
NCT05016674: Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat

Withdrawn
N/A
3
US
LipoLife system
Alma Lasers
Laser Assisted Liposuction
02/23
05/23
Huang, David
ACTIV-4, NCT04505774 / 2020-004285-19: Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE

Completed
4
3591
Europe, US, RoW
theraputic heparin, unfractionated heparin, Enoxaparin, Dalteparin, Tinzaparin, Heparin, prophylactic heparin, enoxaparin, dalteparin, Fondparinux, P2Y12, Ticagrelor, Prasugrel, Clopidogrel, Crizanlizumab Injection, SGLT2 inhibitor, dapagliflozin, empagliflozin, canagliflozin, ertugliflozin
Matthew Neal MD, National Heart, Lung, and Blood Institute (NHLBI)
Covid19
08/23
01/24
PIVATAL, NCT05034432: The Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

Recruiting
4
100
US
Intra-Op Prophylactic VT ablation, Conventional Management
University of Rochester, National Heart, Lung, and Blood Institute (NHLBI)
Arrythmia, Cardiomyopathies
12/25
06/26
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Terminated
3
535
Europe, Canada, Japan, US, RoW
BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo
Remedy Pharmaceuticals, Inc.
Brain Edema, Stroke, Acute
08/23
08/23
ASPIRE, NCT03907046: Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Recruiting
3
700
US
Apixaban, Eliquis, Aspirin
Yale University, National Institute of Neurological Disorders and Stroke (NINDS)
Intracerebral Hemorrhage, Atrial Fibrillation
04/27
04/27
REPAVID-22, NCT05254990 / 2021-006951-32: Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Terminated
3
409
Europe, US, RoW
Reparixin, Repertaxin L-lysine salt, Placebo, Matched placebo
Dompé Farmaceutici S.p.A
Infectious Pneumonia, Severe COVID-19
09/24
09/24
NRG-BN013, NCT06500455: Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Recruiting
3
269
US
Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Fractionated Stereotactic Radiation Therapy, Fractionated Stereotactic Radiotherapy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Stereotactic Radiosurgery, SRS, Stereotactic External Beam Irradiation, stereotactic external-beam radiation therapy, Stereotactic Radiation Therapy, Stereotactic Radiotherapy, stereotaxic radiation therapy, stereotaxic radiosurgery
NRG Oncology, National Cancer Institute (NCI)
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Metastatic Renal Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8
06/28
06/28
NCT04258787: OCT in Fuchs' Dystrophy

Recruiting
N/A
60
US
Oregon Health and Science University, National Eye Institute (NEI)
Fuchs Dystrophy, Pseudophakic Bullous Keratopathy
06/26
06/26
NCT01243931: Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Recruiting
N/A
80
US
OCT-guided laser phototherapeutic keratectomy, Manufacturer/Name OCT Technology 510(K), Optovue/RTVue-CAM Fourier-domain K071250, Bioptigen/Bioptigen Fourier-domain K063343, Zeiss/Visante Time-domain K051789
Oregon Health and Science University, National Eye Institute (NEI)
Corneal Opacity
12/26
12/26
NCT02109471: Observational Study of Corneal Opacities in Adults

Recruiting
N/A
150
US
Oregon Health and Science University, National Eye Institute (NEI)
Corneal Opacities (Scar and Stromal Dystrophy)
12/25
12/25
NCT02026128: Optical Coherence Tomography (OCT) in Uveitis

Recruiting
N/A
75
US
Oregon Health and Science University
Uveitis
12/25
12/25
NCT02141308: OCT in Rare Chorioretinal Diseases

Recruiting
N/A
150
US
Oregon Health and Science University
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
12/25
12/26
NCT03761381: OCT Angiography and NRAI in Dementia

Recruiting
N/A
20
US
Optical Coherence Tomography Angiography (OCTA) Imaging, Noninvasive Retinal Amyloid Imaging (NRAI)
Oregon Health and Science University
Alzheimer Disease, Dementia, Mild Cognitive Impairment
12/25
12/25
NCT03504800: OCT in Diagnosis of Irregular Corneas

Recruiting
N/A
445
US
Optical Coherence Tomography
Oregon Health and Science University
Keratoconus, Corneal Opacity, Corneal Dystrophy
04/25
04/26
OCT IOL, NCT00532051: Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography

Recruiting
N/A
690
US
OCT measurements, Manufacturer/Name OCT Technology 510(K), Optovue/RTVue-CAM Fourier-domain K071250, Bioptigen/Bioptigen Fourier-domain K063343, Zeiss/Visante Time-domain K051789
Oregon Health and Science University, National Eye Institute (NEI)
Cataract
07/26
07/26
NCT04190186: Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation

Completed
N/A
55
US
Insertable Cardiac Monitor, BioMonitor3® or future generation of Biotronik ICM
University of Rochester, Biotronik, Inc.
Persistent Atrial Fibrillation
02/24
02/24
NCT03760432: Collagen Cross-linking in Keratoconus

Recruiting
N/A
100
US
Laser Custom Corneal Collagen Cross-Linking
Oregon Health and Science University, National Eye Institute (NEI)
Keratoconus
12/25
12/25
NCT03809585: Observational Study of Iris Tumors

Recruiting
N/A
100
US
Oregon Health and Science University, National Eye Institute (NEI)
Iris Tumor
12/25
12/25
ICMREDUCE-AF, NCT04922281: Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation

Recruiting
N/A
120
US
Insertable Cardiac Monitor or external non-invasive LT-ECG patch, Confirm Rx™, Carnation Ambulatory Monitor ("CAM™"; Bardy Diagnostics).The CAM™ patch.
University of Rochester, National Heart, Lung, and Blood Institute (NHLBI)
Atrial Fibrillation, Cardiovascular Diseases, Heart Diseases, Arrhythmias, Cardiac, Pathologic Processes
09/25
12/25
NCT04570020: Scleral Lens Fitting Using Wide-Field OCT

Recruiting
N/A
258
US
Oregon Health and Science University, National Eye Institute (NEI)
Keratoconus, Irregular; Contour of Cornea
12/25
12/26
FSOCT, NCT01957267: Functional and Structural Imaging for Glaucoma

Recruiting
N/A
160
US
Oregon Health and Science University, National Eye Institute (NEI)
Glaucoma
05/26
05/26
NCT01931904: Eye Pressure Lowering Surgery

Recruiting
N/A
46
US
Oregon Health and Science University, National Eye Institute (NEI)
Glaucoma
05/26
05/26
VA IR vs IO, NCT05250986: Comparison of Visual Acuity Performed in Office Versus In Residence

Recruiting
N/A
325
US, RoW
GoCheck Kids (iOS), GoCheck Kids (Windows), GoCheck at Home (iOS), GoCheck at Home (Windows)
Gobiquity Mobile Health
Refractive Errors
05/22
09/22
Hwang, Thomas
NCT02141308: OCT in Rare Chorioretinal Diseases

Recruiting
N/A
150
US
Oregon Health and Science University
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
12/25
12/26
NCT02253030: OCT Angiography in Wet AMD

Recruiting
N/A
160
US
Optical Coherence Tomography
Oregon Health and Science University
Neovascular (Wet) Age-related Macular Degeneration (AMD)
12/26
12/26
NCT02330042: OCT Biomarkers for Diabetic Retinopathy

Active, not recruiting
N/A
165
US
Oregon Health and Science University
Diabetic Retinopathy
12/24
12/24
NCT03922932: WF and PR OCTA in Diabetic Retinopathy

Active, not recruiting
N/A
290
US
Oregon Health and Science University
Diabetic Retinopathy
12/25
12/25
Spurgeon, Stephen
EA4181, NCT04115631: A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

Active, not recruiting
2
360
US
Acalabrutinib, ACP-196, Bruton Tyrosine Kinase Inhibitor ACP-196, Calquence, Bendamustine, SDX-105, Bendamustine Hydrochloride, Bendamustin Hydrochloride, Bendeka, Cytostasan Hydrochloride, Levact, Ribomustin, SyB L-0501, Treanda, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Rituximab, ABP 798, BI 695500, C2B8 Monoclonal Antibody, Chimeric Anti-CD20 Antibody, CT-P10, IDEC-102, IDEC-C2B8, IDEC-C2B8 Monoclonal Antibody, MabThera, Monoclonal Antibody IDEC-C2B8, PF-05280586, Rituxan, Rituximab ABBS, Rituximab Biosimilar ABP 798, Rituximab Biosimilar BI 695500, Rituximab Biosimilar CT-P10, Rituximab Biosimilar GB241, Rituximab Biosimilar IBI301, Rituximab Biosimilar JHL1101, Rituximab Biosimilar PF-05280586, Rituximab Biosimilar RTXM83, Rituximab Biosimilar SAIT101, rituximab biosimilar TQB2303, rituximab-abbs, RTXM83, Truxima
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Liver Lymphoma, Mantle Cell Lymphoma
12/25
12/25
NCT06895473: Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

Not yet recruiting
2
22
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-Cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Lumbar Puncture, LP, Spinal Tap, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Jylamvo, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Therapeutic Hydrocortisone, Aeroseb-HC, Barseb HC, Barseb-HC, Cetacort, Cort-Dome, Cortef, Cortenema, Cortifan, Cortisol, Cortispray, Cortril, Dermacort, Domolene, Eldecort, Hautosone, Heb-Cort, Hydrocortisone, Hydrocortone, Hytone, Komed-HC, Nutracort, Proctocort, Rectoid
OHSU Knight Cancer Institute, Oregon Health and Science University, American Society of Clinical Oncology
Hematopoietic and Lymphatic System Neoplasm
04/27
12/27
PRO1160-001, NCT05721222: PRO1160 for Advanced Solid and Liquid Tumors

Recruiting
1/2
134
US, RoW
PRO1160
ProfoundBio US Co.
Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma
11/26
03/27
NCT06357676: Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma

Not yet recruiting
1/2
27
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Echocardiography, EC, FDG-Positron Emission Tomography, FDG, FDG-PET, FDG-PET Imaging, Glofitamab, Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody RO7082859, RO 7082859, RO7082859, Ibrutinib, BTK Inhibitor PCI-32765, CRA-032765, Imbruvica, PCI-32765, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Obinutuzumab, Anti-CD20 Monoclonal Antibody R7159, GA-101, GA101, Gazyva, huMAB(CD20), R7159, RO 5072759, RO-5072759, RO5072759
OHSU Knight Cancer Institute, Oregon Health and Science University, Genentech, Inc.
Mantle Cell Lymphoma
05/27
05/29
NCT06249191: Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

Recruiting
1/2
30
US
Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspiration and Biopsy, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B-518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, WR-138719, Doxorubicin, Adriablastin, Hydroxydaunomycin, Hydroxyl Daunorubicin, Hydroxyldaunorubicin, Echocardiography, EC, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP 16213, VP-16, VP-16-213, VP16, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Mosunetuzumab, Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody BTCT4465A, BTCT 4465A, BTCT-4465A, BTCT4465A, CD20/CD3 BiMAb BTCT4465A, Lunsumio, Mosunetuzumab-axgb, RG 7828, RG-7828, RG7828, RO7030816, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Vincristine, LCR, Leurocristine, VCR, Vincrystine
OHSU Knight Cancer Institute, Genentech, Inc., Oregon Health and Science University
Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma
04/26
04/27
NCT05943496: Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Recruiting
1
25
US
Acalabrutinib, ACP-196, Bruton Tyrosine Kinase Inhibitor ACP-196, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, CT, CT Scan, tomography, Echocardiography, EC, Obinutuzumab, Anti-CD20 Monoclonal Antibody R7159, GA-101, GA101, Gazyva, huMAB(CD20), R7159, RO 5072759, RO-5072759, RO5072759, Questionnaire Administration, Tafasitamab, Immunoglobulin, Anti-(Human Cd19 Antigen) (Human-mus musculus Monoclonal MOR00208 Heavy Chain), Disulfide with Human-mus musculus Monoclonal MOR00208 .Kappa.-chain, Dimer, Monjuvi, MOR-00208, MOR00208, MOR208, Tafasitamab-cxix, XmAb5574
OHSU Knight Cancer Institute, Oregon Health and Science University, Incyte Corporation
Chronic Lymphocytic Leukemia
01/26
01/27
Davidson, Brian R
EMT2, NCT03428477 / 2016-000628-24: EPA for Metastasis Trial 2

Active, not recruiting
3
418
Europe
Icosapent Ethyl, Vascepa, Placebo
Mark A Hull, PhD FRCP, Yorkshire Cancer Research, Amarin Pharma Inc.
Liver Metastasis, Colon Cancer
11/25
04/26
NCT03195556: Augmentation of Limb Perfusion With Contrast Ultrasound

Recruiting
N/A
30
US
Ultrasound, Contrast ultrasound
Oregon Health and Science University
Peripheral Arterial Disease
12/19
12/19
Vaseghi, Marmar
PREVENT VT, NCT01013714: Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias

Recruiting
3
40
US
Cardiac Sympathetic Denervation (CSD), Routine Care
University of California, Los Angeles, Oregon Health and Science University
Sudden Cardiac Death, Ventricular Tachycardia, Ventricular Fibrillation, Cardiomyopathy
08/24
08/24
NCT04387435: Optimization of VNS in Epileptic Patients to Induce Cardioprotection

Completed
N/A
1
US
A change or titration in the current or frequency settings of the VNS therapy system.
University of California, Los Angeles, National Institutes of Health (NIH)
Epilepsy, Sudden Cardiac Death
07/21
07/21
NCT04359004: A Study to Evaluate the Effect of Vagus Nerve Stimulation in Patients Undergoing VT Ablation

Completed
N/A
5
US
Vagus Nerve Stimulation (VNS)
University of California, Los Angeles, National Institutes of Health (NIH)
Arrhythmia, Ventricular Tachycardia (VT)
06/23
10/23
tVNS_POAF, NCT04514757: Transcutaneous (Tragus) Vagal Nerve Stimulation for Post-op Afib

Completed
N/A
77
US
active tVNS, sham tVNS
University of California, Los Angeles, University of Oklahoma
Atrial Fibrillation
03/24
04/24
Klein, Michael
AMLSG BiO, NCT01252485: Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - the Biology and Outcome (BiO)-Project

Recruiting
N/A
50000
Europe
University of Ulm
Acute Myeloid Leukemia (AML), MDS/AML
12/44
12/44
NCT02141308: OCT in Rare Chorioretinal Diseases

Recruiting
N/A
150
US
Oregon Health and Science University
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
12/25
12/26
NCT02253030: OCT Angiography in Wet AMD

Recruiting
N/A
160
US
Optical Coherence Tomography
Oregon Health and Science University
Neovascular (Wet) Age-related Macular Degeneration (AMD)
12/26
12/26
King, Laurie
reTURN, NCT03892291: Objective Dual-task Turning Measures for Return-to-duty Assessments

Active, not recruiting
N/A
140
US
Oregon Health and Science University, Courage Kenny Research Center, University of Utah, Fort Sam Houston, Warrior Recovery Center, Madigan Army Medical Center
Mild Traumatic Brain Injury, Gait, Balance, Veterans, Mobility
08/24
08/24
NCT03479541: Can Early Initiation of Rehabilitation With Wearable Sensor Technology Improve Outcomes in mTBI?

Active, not recruiting
N/A
160
US
Rehabilitation
Oregon Health and Science University, United States Department of Defense
Mild Traumatic Brain Injury, Balance; Distorted, Gait, Unsteady, Quality of Life, Veterans
09/23
09/23
SuBTyPE, NCT06381674: Wearable Technology to Characterize and Treat mTBI Subtypes: Biofeedback-Based Precision Rehabilitation

Recruiting
N/A
100
US
Vestibular therapy for mTBI augmented with audio and visual real-time biofeedback, Rehabilitation, Vestibular therapy for mTBI
Oregon Health and Science University, United States Department of Defense
Mild Traumatic Brain Injury, Concussion, Rehabilitation, Balance Impairment
09/28
09/28
NCT05680597: Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease

Recruiting
N/A
80
US
Balance Tele-Rehabilitation Agility Boot Camp (ABC), Opal sensors; APDM Wearable Technologies
Oregon Health and Science University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Parkinson Disease
06/27
06/27
Cichowski, Sara
RELIEF, NCT05512039: Reduced-dose Botox for Urgency Incontinence Among Elder Females

Recruiting
1/2
376
US
Botox 50 Unit Injection, OnabotulinumtoxinA 50 Unit Injection, Botox 100 Unit Injection, OnabotulinumtoxinA 100 Unit
Dartmouth-Hitchcock Medical Center, Patient-Centered Outcomes Research Institute, Dartmouth College, University of Alabama at Birmingham, University of Pittsburgh, University of Texas, Kaiser Permanente, Oregon Health and Science University, Stanford University, University of Connecticut, University of Nebraska
Overactive Bladder, Urinary Incontinence in Old Age, Urgency Urinary Incontinence
09/26
01/27
NCT05950633: Postoperative Active Recovery

Active, not recruiting
N/A
72
US
Standard of Care, Active Recovery
Oregon Health and Science University
Pelvic Floor Disorders
04/25
04/25
Lauer, Andreas
NCT02141308: OCT in Rare Chorioretinal Diseases

Recruiting
N/A
150
US
Oregon Health and Science University
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
12/25
12/26
NCT02253030: OCT Angiography in Wet AMD

Recruiting
N/A
160
US
Optical Coherence Tomography
Oregon Health and Science University
Neovascular (Wet) Age-related Macular Degeneration (AMD)
12/26
12/26
NCT03922932: WF and PR OCTA in Diabetic Retinopathy

Active, not recruiting
N/A
290
US
Oregon Health and Science University
Diabetic Retinopathy
12/25
12/25
Bailey, Steven
NCT02141308: OCT in Rare Chorioretinal Diseases

Recruiting
N/A
150
US
Oregon Health and Science University
Retinal Artery Occlusions, Polypoidal Choroidal Vasculopathy, Retinal Arterial Macroaneurysm, Juxtafoveal Telangiecasia, Central Serous Chorioretinopathy
12/25
12/26
NCT02253030: OCT Angiography in Wet AMD

Recruiting
N/A
160
US
Optical Coherence Tomography
Oregon Health and Science University
Neovascular (Wet) Age-related Macular Degeneration (AMD)
12/26
12/26
CHIPAHA, NCT00763828: Can Hypothermia be Incorporated Into Primary Angioplasty for Heart Attack?

Not yet recruiting
N/A
20
US
Life Recovery Systems ThermoSuit, Life Recovery Systems ThermoSuit(R) System
Life Recovery Systems
ST-Elevation Myocardial Infarction
02/25
05/25
Taylor, Matthew
OpcemISA, NCT03669718 / 2018-000789-13: A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Active, not recruiting
2
194
Europe, US, RoW
ISA101b, Cemiplimab, Placebo
ISA Pharmaceuticals, Regeneron Pharmaceuticals
Squamous Cell Carcinoma of the Oropharynx, HPV16 Positive
09/24
06/25
NCT05308901: Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma

Active, not recruiting
2
6
US
Pembrolizumab, Keytruda, Lenvatinib
Providence Health & Services, Merck Sharp & Dohme LLC, Eisai Inc.
Melanoma, Uveal
12/24
06/27
CA209-73R, NCT04061980: Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer

Active, not recruiting
2
24
US
Binimetinib, ARRY-162, ARRY-438162, MEK162, Mektovi, Encorafenib, Braftovi, LGX 818, LGX-818, LGX818, Nivolumab, BMS-936558, MDX-1106, NIVO, ONO-4538, Opdivo
Providence Health & Services, Providence Cancer Center, Earle A. Chiles Research Institute
BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma, Refractory Thyroid Gland Carcinoma, Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8, Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8, Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
10/25
10/27
NCT04938609: Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

Active, not recruiting
2
28
US
Pembrolizumab, Keytruda, Stereotactic Body Radiation Therapy (5 days), Surgical Resection
Providence Health & Services, Providence Cancer Center, Earle A. Chiles Research Institute
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
01/27
01/31
NCT05200143: Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma

Terminated
2
4
US
Ipilimumab, Nivolumab, BMS-936558, MDX1106, ONO-4538, Cabozantinib, XL184
Providence Health & Services, Bristol-Myers Squibb, Exelixis
Refractory Cutaneous Melanoma
09/23
07/24
NCT05913388: GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma

Recruiting
2
92
US
GB1211, Pembrolizumab, Keytruda, Placebo
Providence Health & Services, Providence Cancer Center, Providence Cancer Center, Earle A. Chiles Research Institute, Galecto Biotech AB
Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma
02/28
02/30
BA3071-001, NCT05180799: A Phase 1/2 Study of BA3071 in Patients With Solid Tumors

Recruiting
1/2
320
US, RoW
BA3071, Nivolumab, Pembrolizumab, Pemetrexed (Alimta)
BioAtla, Inc.
NSCLC, Melanoma
12/25
06/26
KEYNOTE-E64, NCT04787042: Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Recruiting
1/2
316
US
ST-067, Obinutuzumab 25 MG/1 ML Intravenous Solution [GAZYVA], GAZYVA, pembrolizumab, KEYTRUDA®
Simcha IL-18, Inc., Merck Sharp & Dohme LLC
Cancer, Solid Tumor, Melanoma, Renal Cell Carcinoma, Triple-negative Breast Cancer, Non Small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Carcinoma, MSI-High
06/25
12/25
EP0031-101, NCT05443126: A Study of EP0031 in Patients With Advanced RET-altered Malignancies

Recruiting
1/2
265
Europe, US, RoW
EP0031
Ellipses Pharma
Advanced Solid Tumor
12/26
06/27
IO-108-CL-001, NCT05054348: First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors

Completed
1
91
US
IO-108, IO-108 + pembrolizumab combination therapy, IO-108 + Keytruda combination therapy, IO-108 + cemiplimab combination therapy, IO-108 + Libtayo combination therapy
Immune-Onc Therapeutics, Regeneron Pharmaceuticals
Solid Tumor, Adult
04/24
05/24
NCT01107522: Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Active, not recruiting
1
100
US
CTO, CTO and Temodar®, CTO, Temodar®, Radiation therapy
Tactical Therapeutics, Inc.
Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas
01/25
01/26
RIDGE-1, NCT06228924: Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults with PKP2 Mutation-associated ARVC

Recruiting
1
15
US
TN-401
Tenaya Therapeutics, Johns Hopkins University, Mayo Clinic
Arrhythmogenic Right Ventricular Cardiomyopathy
05/26
10/29
STARLING, NCT05576077: A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

Terminated
1
31
Canada, US
TBio-4101, TIL, autologous, tumor-reactive, T-cell product, Pembrolizumab, Keytruda
Turnstone Biologics, Corp.
Breast Cancer, Colorectal Cancer, Uveal Melanoma, Cutaneous Melanoma, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma
02/25
02/25
NCT03882437: Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B

Active, not recruiting
1
7
US
RP-A501
Rocket Pharmaceuticals Inc.
Danon Disease
03/25
03/25
C-1100-01, NCT04121676: Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

Completed
1
91
US
AGEN2373, Anti-CD137, Botensilimab, AGEN1181, Anti-CTLA-4
Agenus Inc.
Advanced Cancer
02/24
11/24
RIDGE, NCT06311708: Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Recruiting
N/A
200
Europe, US
Tenaya Therapeutics, University of California, San Francisco, Brigham and Women's Hospital, New York University, University of Colorado, Denver, Johns Hopkins University, The Cleveland Clinic, Mayo Clinic, Medical University of South Carolina, Hopital Louis Pradel, Istituti Clinici Scientifici Maugeri SpA, The Queen Elizabeth Hospital, St George's University Hospitals NHS Foundation Trust, Royal Brompton & Harefield NHS Foundation Trust, Barts & The London NHS Trust, Skane University Hospital, Centro Cardiologico Monzino, Hôpital Haut-Lévêque, Nantes University Hospital, Pitié-Salpêtrière Hospital, Wuerzburg University Hospital, University Hospital Muenster
Arrhythmogenic Right Ventricular Cardiomyopathy
03/30
07/30
NCT05389514: Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Temporarily Not Available
N/A
NA
Cyclophosphamide, Cytoxan, Cytoxan Lyophilized, Cy, Gemcitabine, Gemzar, Pembrolizumab, KEYTRUDA, MK-3475, Cell Infusion
Providence Health & Services
KRAS G12V Mutant Advanced Epithelial Cancers
 
 
NCT06214507: Danon Disease Natural History Study

Recruiting
N/A
46
Europe, US, RoW
No intervention
Rocket Pharmaceuticals Inc.
Danon Disease
08/26
08/26
kidNEY-VNS, NCT05588063: taVNS for FRNS in Children

Recruiting
N/A
30
US
Transcutaneous auricular vagus nerve stimulation, Roscoe TENS 7000, Sham device
Northwell Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis
08/25
08/25
CABA, NCT05383833: Creatine to Augment Bioenergetics in Alzheimer's

Completed
N/A
20
US
Creatine Monohydrate
University of Kansas Medical Center, Alzheimer's Association
Alzheimer's Disease
05/24
05/24
kidNEY-VNS, NCT05583942: A Pilot Trial of taVNS for SRNS in Children

Recruiting
N/A
10
US
trascutaneous auricular vagus nerve stimulation, Roscoe TENS 7000, Sham device
Northwell Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nephrotic Syndrome in Children, Minimal Change Disease, Focal Segmental Glomerulosclerosis
04/25
08/25
Edmunds, Beth
FSOCT, NCT01957267: Functional and Structural Imaging for Glaucoma

Recruiting
N/A
160
US
Oregon Health and Science University, National Eye Institute (NEI)
Glaucoma
05/26
05/26
NCT01931904: Eye Pressure Lowering Surgery

Recruiting
N/A
46
US
Oregon Health and Science University, National Eye Institute (NEI)
Glaucoma
05/26
05/26
Skalet, Alilson
NCT01955915: Blood Vessel Patterns in Small Choroidal Tumors

Active, not recruiting
N/A
15
US
OHSU Knight Cancer Institute
Small Posterior Choroidal Tumors
04/15
12/23
Skalet, Alison
AL, NCT05844982: Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 Mg) Intravitreal Implants Vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Recruiting
3
600
US
Faricimab, fluocinolone acetonide
Jaeb Center for Health Research, National Eye Institute (NEI), National Institutes of Health (NIH), Alimera Sciences, Genentech, Inc.
Radiation Retinopathy, Visual Impairment
12/29
12/29
NCT01955941: Vascular Response to Brachytherapy Using Functional OCT

Completed
N/A
49
US
OHSU Knight Cancer Institute
Uveal Melanoma
11/21
11/21
NCT05266430: Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)

Terminated
N/A
2
US
Standard of Care, AU-011, belzupacap sarotalocan, bel-sar
Aura Biosciences
Choroidal Melanoma, Indeterminate Lesions
02/23
04/23
Hung, Arthur
NCT02565498: Preoperative vs Postoperative IMRT for Extremity/Truncal STS

Active, not recruiting
3
210
Europe, Canada, US
Preoperative intensity modulated radiation therapy, Postoperative intensity modulated radiation therapy
Mount Sinai Hospital, Canada, Princess Margaret Hospital, Canada
Adult Soft Tissue Sarcoma
10/24
05/29
DEBRA, NCT04852887: De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer

Recruiting
3
1670
Canada, Japan, US, RoW
Radiation and Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane), Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane)
NRG Oncology, National Cancer Institute (NCI)
Stage I Breast Cancer
01/26
07/41
 

Download Options